期刊文献+

经皮冠状动脉介入术前应用不同剂量氯吡格雷的疗效与安全性 被引量:4

Efficacy and Safety of Different dose of Clopidogrel Before the Application of Percutaneous Coronary Intervention
下载PDF
导出
摘要 目的在经皮冠状动脉介入术(PCI)前应用高剂量(450 mg)氯吡格雷和常规剂量(300 mg)氯吡格雷预治疗的临床疗效及安全性研究。方法将我院206例拟行PCI患抽签随机分为高剂量组与常规剂量组,每组103例,术前分别给予450 mg、300 mg氯吡格雷预治疗,比较两组血小板活化指标、血小板聚集率,并随访30 d、6个月对心血管事件及出血事件进行记录。结果高剂量组CD63、CD62 P、TSP各为(4.13±1.34)%、(8.22±3.46)%、(2.54±0.34)%与常规剂量组(5.32±2.31)%、(10.52±4.11)%、(2.90±0.54)%比较为低(P<0.05);两组MAADP及血小板聚集率治疗后显著下降(P<0.05),血小板抑制率显著上升(P<0.05),组间比较用药后MAADP、血小板抑制率、血小板聚集率差异显著(P<0.05);高剂量组30 d、6月联合终点事件发生率分别为0.0%、1.9%低于常规剂量组3.9%、8.7%,但无显著差异(P>0.05),总发生率高剂量组30 d、6月后分别为13.6%、22.3%,均显著低于常规剂量组32.0%、58.3%,对比差异显著(P<0.05);两组不同时间点出血时间比较差异无统计学意义(P>0.05)。结论 PCI术前应用450 mg高负荷的血小板抑制效果优于常规300 mg剂量,可降低不良事件发生率。 Objective To study the clinical efficacy and safety Before percutaneous coronary intervention(PCI) application of high doses (450 rag)and conventional dose (300 rag)of clopidogrel pretreatment. Methods 206 patients scheduled for PCI patients were randomly divided into high dose group and routine dose group, 103 cases of each,were given 450 rag,300 mg clopidogrel pretreatment during preoperative, compared two groups of platelet maximum aggregation rate (MPAR) , follow-up 30 d, 6 months, recorded on cardiovascular events and bleeding events. Results High dose group of CD63, CD62 P,TSP(4.13 + 1.34) % , (8. 22 +3.46) %, (2.54 + 0.34)%, compared to conventional dose group (5.32 + 2.31 ) %, ( 10.52 + 4. 11 ) %, (2.90 + 0.54 ) %, was significantly lower, difference was significant ( P 〈 0.05 ) ; In high dose group, 30 d,6 month combined end point events rate were respectively 0.0% , 1.9% , was lower than that of the conventional dose group 3.9% ,8.7% ,difference had no significant(P 〉 0.05) ,the total incidence rate of 30 d of high dose group,after 6 month were respectively 13.6% ,22.3% ,were significantly lower than that of routine dose group 32% ,58.3% , difference was significant(P 〈 0.05) ;the two group at different time points of bleeding time difference had not significant( P 〉 0.05 ). Conclusion 450 mg high load by platelet inhibition effect is better than that of conventional 300 mg dose according to PCI before the operation,can reduce the in- cidence of adverse events, has a high value in clinical application.
出处 《血栓与止血学》 2015年第4期212-214,217,共4页 Chinese Journal of Thrombosis and Hemostasis
关键词 经皮冠状动脉介入术 氯吡格雷 Percutaneous coronary intervention Clopidogrel
  • 相关文献

参考文献5

二级参考文献26

  • 1韩雅玲.抗血小板药物在冠心病介入治疗中的应用[J].中国实用内科杂志,2005,25(1):21-23. 被引量:38
  • 2陈军,周颖玲,杨希立,黄文辉,李健民,周昭伦.罗格列酮对2型糖尿病患者冠脉支架内再狭窄的预防作用[J].中国临床药学杂志,2005,14(4):223-225. 被引量:10
  • 3李志娟,董平栓,杨旭明,李转珍,杨喜山,王绍欣,尚喜艳,汪砚雨,朱继红,杜来景,王可,闫鹏,颛丽丽.国产和进口氯吡格雷对经皮冠状动脉介入术后血小板功能的影响[J].中国介入心脏病学杂志,2006,14(4):208-210. 被引量:24
  • 4Smith SC Jr,Dove JT,Jacobs AK,et al.ACC/AHA guidelines for percutaneus coronary intervention:A report of ACC/AHA task force on practice guidelines.J Am Coil Cardiol,2001,37:2215-2238.
  • 5Steinhubl SR,Berger PB,Mann yr,et al.Early and sustained dual oral antiplatelet therapy following pereutaneus comnary intervention.JAMA.2002,288:2411-2420.
  • 6Orford JL,Fasseas P,Melby S,et al.Safety and effycacy of aspirin,clopidogrel,and warfarin after coronary stent placement in patients with an indication for anficoagulation.Am Heart J,2004,147:4632-4637.
  • 7Smith S C Jr,Feldman T E,Hirshfeld J W Jr,Jacobs AK,Kern M J,King S B 3rd,et al. ACC/AHA/SCAI.2005 guideline update for percutaneous coronary inter-vention:a report of the American College of Cardiolo-gy/American Heart Association Task Force On PracticeGuidelines (ACC/ AH A/ SC AI Writing Committee toupdate the 2001 guidelines for pereutmmous coronaryintervention)[J],J Am Coll Cardiol,2006 ,47 :el-el21.
  • 8Tolleson T R,Newby L K,Harrington R A,Bhapkar MV,Verheugt F W,Berger P B,et al. Frequency of stentthrombosis after acute coronary syndromes (from theSYMPHONY and 2nd SYMPHONY trials)[J].Am JCardiol,2003,92 :330-333.
  • 9Fifi J T,Brockington C,Narang J,Leesch W,Ewing SL,Bennet H,et al. Clopidogrel resistance is associatedwith thromboembolic complications in patients undergo-ing neurovascular stenting[J].AJNR Am J Neuroradi-ol,2013 ,34 :716-720.
  • 10Simon T,Verstuyft C,Mary-Krause M,Quteineh L,Drouet E,Meneveau N,et al. Genetic determinants ofresponse to clopidogrel and cardiovascular events [J].NEngl J Med,2009,360:363-375.

共引文献17

同被引文献24

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部